Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow Transplantation
Raleigh A. Bowden(Fred Hutch Cancer Center), Joel D. Meyers(Public Health – Seattle & King County), M Banaji, Merlin H. Sayers, E. Donnall Thomas(AbbVie (United States)), Barbara Newton, Nancy Flournoy(University of Missouri)
Cited by 525
Related Papers
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Antileukemic Effect of Chronic Graft-versus-Host Disease
|New England Journal of Medicine|1981|1.1k
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
|New England Journal of Medicine|1993|848